Cover Image

TOXIC EPIDERMAL NECROLYSIS INDUCED BY LAMOTRIGINE IN A PATIENT

RASMI HANAN I

Abstract


Toxic epidermal necrolysis is an unpredictable and severe adverse drug reaction. In toxic epidermal necrolysis epidermal damage appears to result from keratinocyte  apoptosis. This condition is triggered by many factors   principally drugs such as antiepileptic medications antibiotics particularly sulfonamides nonsteroidal anti-inflammatory drugs allopurinol and nevirapine. Lamotrigine has been reported potentially to cause serious cutaneous reactions. We describe a case of a eleven yr old male who developed toxic epidermal necrolysis after treatment with lamotrigine, and who was  diagnosed both clinically and pathologically. Children are more susceptible to lamotrigine-induced rash than adults and risk of serious rash can be lessened by strict adherence to dosing guidelines. In our case the patient was administered a higher dose than the required regimen. Therefore clinicians should strictly adhere to the dose regimen when using  lamotrigine especially in children.

 


Full Text:

PDF

References


Nelson text book of paediatrics 20th edition

Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: A case-control study. Study group of the International case control study on severe cutaneous adverse reactions. Lancet.1999; 353:2190–4.

Sanmarkan AD, Sori T, Thappa DM, Jaisankar TJ. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis over a period of 10 years. Indian J Dermatol. 2011;56 :25–9

Barvaliya M, Sanmukhani J, Patel T, Paliwal N, Shah H, Tripathi C. Drug-induced Stevens- Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: A multicentric retrospective study. J Postgrad Med.2011;57:115–9.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University